Why the study?
Does abrupt propranolol withdrawal induce a rebound hyperinotropic state in healthy subjects?
Does abrupt propranolol withdrawal induce a rebound hyperinotropic state in healthy subjects?
Abrupt withdrawal of propranolol in healthy subjects does not lead to a rebound hyperinotropic state as measured by systolic time intervals and VMA excretion.
No rebound hyperinotropy after propranolol withdrawal in healthy subjects; leaves open effects in patients with cardiovascular disease.
Acute coronary artery syndromes, including unstable angina and myocardial infarction, have been described after the abrupt withdrawal of β-adrenergic blocking agents. One possible mechanism is a hyperinotropic state resulting from a rebound hypersensitivity to endogenous catecholamines. Propranolol hydrochloride was administered to 21 healthy subjects for 15 days. Systolic time intervals and 24-hour urinary excretion of vanillylmandelic acid (VMA) were measured serially before, during, and after administration. Serial serum propranolol levels were measured during and after administration. Inhibition of exercise-induced tachycardia by propranolol was established before and during drug administration. Although there were therapeutic serum levels of propranolol and a significant decrease in the resting and exercise heart rate (P<.001 andP<.001, respectively), the systolic time intervals and VMA excretion measured during the withdrawal period did not differ from baseline levels. Thus, there was no evidence of a rebound hyperinotropic state. (Arch Intern Med136:867-871, 1976)
No takes yet. Share an insight, caveat, or question.
James A. Pantano (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: